DNA
Ginkgo Bioworks Holdings, Inc.
Set alert
- YTD
- +34.90%
- 1 year
- -6.66%
- Open
- 12.12
- Prev close
- 12.74
- Mkt cap
- 754.88M
- Vol
- 2.73M
- Avg vol
- 2.19M
- EPS
- -5.06
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.61
- High
- 12.61
- Forward P/E
- -5.17
- Beta
- 1.79
- Short ratio
- 6.35
- Inst. own
- 73.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 8.08
- 200-d avg
- 8.32
- 1y target
- 7.00
News
1 day ago zacks.com
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.74 in the latest trading session, marking a -4.35% move from the prior day.
1 day ago fool.com
Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.
Should investors follow Wood's lead with this eVTOL manufacturer?
1 week ago businessinsider.com
Hugging Face is launching a new AI model that lets scientists 'chat with DNA'
Hugging Face released a new AI model that allows users to "chat with DNA." Carbon-X can analyze and generate DNA and allows researchers to ask questions in plain language.
1 week ago globenewswire.com
Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™
Findings suggest a dual mechanism of action for REYOBIQ against cancer cells New findings revealed potential dual mechanism as combinations with checkpoint blockade further enhanced REYOBIQ…
1 week ago zacks.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Ginkgo Bioworks Holdings, Inc. (DNA) reached $9.86 at the closing of the latest trading day, reflecting a -2.09% change compared to its last close.
2 weeks ago zacks.com
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
In the most recent trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $11.53, indicating a -1.96% shift from the previous trading day.
-
2 weeks ago benzinga.com
TD Cowen Maintains Hold on Ginkgo Bioworks Holdings, Raises Price Target to $11
TD Cowen analyst Brendan Smith maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Hold and raises the price target from $9 to $11.
3 weeks ago benzinga.com
Glaukos Reveals Superior Intraocular Pressure Reduction With Novel Eye Therapy
Glaukos reports positive Phase 4 results for its iDose TR therapy, demonstrating superior efficacy over standalone cataract surgery.
3 weeks ago benzinga.com
What's Going on With Ginkgo Bioworks Stock on Friday?
Ginkgo Bioworks Inc. (NYSE:DNA) is strengthening national biotechnology infrastructure by granting remote laboratory access through the National Science Foundation's X-Labs program and integrating…
3 weeks ago benzinga.com
What's Going on With Ginkgo Bioworks Stock on Friday?
Ginkgo Bioworks offers remote autonomous lab access to NSF X-Labs and integrates Araceli imaging into its Boston platform.
3 weeks ago benzinga.com
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.
3 weeks ago prnewswire.com
Araceli Biosciences und Ginkgo Bioworks ermöglichen die zelluläre Bildgebung in großem Maßstab für das „Lab-in-the-Loop"-System von Nebula
/PRNewswire/ -- Araceli Biosciences und Ginkgo Bioworks (NYSE: DNA) gaben heute die Integration des Endeavor-High-Content-Imaging-Geräts von Araceli in
-
3 weeks ago benzinga.com
Ginkgo Bioworks To Provide Autonomous Lab Access To NSF X-Labs Researchers, Contributing Cloud Lab Time And Protein Testing Services To $1.5B Science Program; To Provide Cloud Lab Time And Remote Access For NSF X-Labs Teams; To Offer Protein Testing Services To NSF X-Labs Teams
Ginkgo Bioworks (NYSE:DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to support the National Science Foundation’s X-Labs program. Ginkgo’s support was…
3 weeks ago businesswire.com
Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to support the National Science Foundation's X-Labs…
3 weeks ago prnewswire.com
Araceli Biosciences y Ginkgo Bioworks incorporan la obtención de imágenes celulares al laboratorio de Nebula
/PRNewswire/ -- Araceli Biosciences y Ginkgo Bioworks (NYSE: DNA) han dado a conocer hoy la integración del instrumento de imágenes de alto contenido Endeavor
-
3 weeks ago benzinga.com
Ginkgo Bioworks To Integrate Araceli Biosciences' Endeavor High-Content Imaging Instrument Into Nebula, The Company's Autonomous Lab
The Endeavor, the world's fastest high-content imaging system, brings cellular imaging with real-time analysis to Nebula's existing technologies, giving researchers the large, curated datasets needed…
3 weeks ago prnewswire.com
Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
The Endeavor® adds the fastest high-content cellular data generation to Ginkgo's around-the-clock research PORTLAND, Ore. and BOSTON, Oct. 8, 2026 /PRNewswire/ -- Araceli Biosciences and Ginkgo…
3 weeks ago zacks.com
Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $11.47, moving 7.57% from the previous trading session.
3 weeks ago defenseworld.net
Ginkgo Bioworks (NYSE:DNA) Hits New 1-Year High – Time to Buy?
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA - Get Free Report) reached a new 52-week high on Tuesday. The company traded as high as $18.22 and last traded at $15.5170, with a volume of 2024663 shares.…
3 weeks ago benzinga.com
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
U.S. stocks rose; Apogee surged 10% on strong results and raised guidance, while Option Care, Ginkgo, PacBio and others posted double-digit gains.
3 weeks ago defenseworld.net
Ginkgo Bioworks (NYSE:DNA) Sees Unusually-High Trading Volume – Should You Buy?
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA - Get Free Report) saw unusually-strong trading volume on Monday. Approximately 2,686,466 shares changed hands during mid-day trading, an increase of 111%…
3 weeks ago fool.com
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
Ginkgo Bioworks and Eli Lilly announced a partnership last month focused on AI drug discovery. The stock has skyrocketed since the partnership was announced.
4 weeks ago zacks.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, Ginkgo Bioworks Holdings, Inc. (DNA) stood at $12.5, denoting a -2.57% move from the preceding trading day.
1 month ago benzinga.com
Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday
Nasdaq fell 150+ points, while Everpure jumped 14% after unveiling growth plans and a FY2028 outlook; other stocks also gained.
1 month ago globenewswire.com
Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel Agreement would…
1 month ago zacks.com
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.58, marking a -8.43% move from the previous day.
1 month ago zacks.com
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?
Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near…
1 month ago zacks.com
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts
Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $7.06, signifying a +1% move from its prior day's close.
-
1 month ago benzinga.com
BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target
BTIG analyst Mark Massaro reiterates Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and maintains $5 price target.
2 months ago benzinga.com
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
-
2 months ago benzinga.com
TD Cowen Downgrades Ginkgo Bioworks Holdings to Hold, Lowers Price Target to $9
TD Cowen analyst Brendan Smith downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Buy to Hold and lowers the price target from $12 to $9.
-
5 months ago benzinga.com
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness Nationwide
https://www.cdc.gov/ebola/situation-summary/index.html
-
6 months ago benzinga.com
ProQR Therapeutics Collaborates With Ginkgo Bioworks Over Access To 50+ Instrument Autonomous Lab Nebula
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today…
-
7 months ago benzinga.com
BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $5
BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $9 to $5.
7 months ago benzinga.com
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
Elon Musk tweeted about wanting Jurassic Park in real life. Companies aren't bringing back dinosaurs yet, but they are bringing extinct items back to life.
-
8 months ago benzinga.com
Ginkgo Bioworks Rolls Out Ginkgo Cloud Lab
Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to Ginkgo's autonomous lab infrastructure…
8 months ago benzinga.com
Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)
Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)
8 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
8 months ago benzinga.com
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter
Ginkgo Bioworks stock drops after earnings miss, lower sales, and shift to autonomous labs and robotics focus.
8 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
8 months ago benzinga.com
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
-
8 months ago benzinga.com
Ginkgo Bioworks To Spin Off Biosecurity Business To Investor Consortium In Exchange For A Minority Equity Position In The Business Alongside The Investors
Ginkgo today announced it has reached an agreement to sell the Company's biosecurity business to a consortium of investors ("Investors") in exchange for a minority equity position in the business…
-
8 months ago benzinga.com
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.36) by 3.68 percent. This is a 29.5 percent increase over losses…
8 months ago benzinga.com
Earnings Scheduled For February 26, 2026
Earnings Scheduled For February 26, 2026
8 months ago benzinga.com
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
8 months ago benzinga.com
Why Roblox Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Why Roblox Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
-
8 months ago benzinga.com
Ginkgo Bioworks Demonstrates, In Collaboration With OpenAI, An AI System That Autonomously Designed, Executed, And Learned From Biological Experiments With Minimal Human Involvement; Co. Reports The System Reduced Cell-Free Protein Synthesis Reaction Costs By 40% Relative To State Of The Art; GPT-5-Driven Autonomous Lab Executed Over 36,000 Experiments
Ginkgo Bioworks (NYSE:DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned from biological experiments with minimal…
-
9 months ago benzinga.com
TD Cowen Maintains Buy on Ginkgo Bioworks Holdings, Lowers Price Target to $12
TD Cowen analyst Brendan Smith maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy and lowers the price target from $14 to $12.
10 months ago benzinga.com
Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans
Ginkgo Bioworks shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership with Carnegie Mellon University.